ArticleJournal of translational medicine2024

IκBα kinase inhibitor BAY 11-7082 promotes anti-tumor effect in RAS-driven cancers.

Praveen Guruvaiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.